Literature DB >> 10572989

Minimally invasive treatment of infection staghorn stones with shock wave lithotripsy and chemolysis.

H G Tiselius1, E Hellgren, A Andersson, A Borrud-Ohlsson, I Eriksson.   

Abstract

We report the results in 118 patients with infection staghorn stones treated with an anaesthesia-free minimally invasive method that combined repeated shock-wave lithotripsy (SWL) sessions (unmodified Dornier HM3 lithotripter) and percutaneous chemolysis with Renacidin. The stone-free rate was 60%. In 27 consecutive patients with infection staghorn stones representative of patients with this stone type in the population, a stone-free rate of 77% was recorded. The latter figure is comparable with results reported for open surgery, percutaneous surgery and sandwich therapy, and superior to that recorded with SWL alone. During the study period, no patient referred to us with an infection staghorn stone was treated with percutaneous, ureteroscopic or open surgery, and all treatments were carried out without regional or general anaesthesia. The described treatment concept had a very low complication rate, but required a fairly long hospital stay, with a mean of 32 days (range: 5-82). The long period necessary for completing the treatment in the most complicated cases might render the procedure less attractive as a standard method, but it is nevertheless an excellent option in high-risk patients and in all those patients in whom other procedures are impossible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572989

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  7 in total

Review 1.  Aspects on how extracorporeal shockwave lithotripsy should be carried out in order to be maximally effective.

Authors:  Hans-Göran Tiselius; Christian G Chaussy
Journal:  Urol Res       Date:  2012-06-27

Review 2.  Engineering Better Lithotripters.

Authors:  Christian G Chaussy; Hans-Göran Tiselius
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

3.  Stones: Guidelines reignite interest in medical treatment of stones.

Authors:  Hans-Göran Tiselius
Journal:  Nat Rev Urol       Date:  2014-08-12       Impact factor: 14.432

Review 4.  Renal struvite stones--pathogenesis, microbiology, and management strategies.

Authors:  Ryan Flannigan; Wai Ho Choy; Ben Chew; Dirk Lange
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

Review 5.  The current role of percutaneous chemolysis in the management of urolithiasis: review and results.

Authors:  Stefanos Kachrilas; Athanasios Papatsoris; Christian Bach; Andreas Bourdoumis; Faruquz Zaman; Junaid Masood; Noor Buchholz
Journal:  Urolithiasis       Date:  2013-06-07       Impact factor: 3.436

Review 6.  Management of staghorn renal stones.

Authors:  Akif Diri; Banu Diri
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

7.  Case of the month from Lillebaelt hospital, University Hospital of South Denmark, Denmark: Renacidin® - still a useful adjunct to endoscopic surgery for complex renal struvite stone disease.

Authors:  Louise Faurholt Øbro; Susanne Sloth Osther; Palle Jörn Sloth Osther; Helene Jung
Journal:  BJU Int       Date:  2022-10       Impact factor: 5.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.